![](/img/cover-not-exists.png)
Rationale for the advancement of PI3K pathway inhibitors for personalized chordoma therapy
Michmerhuizen, N. L., Owen, J. H., Heft Neal, M. E., Mann, J. E., Leonard, E., Wang, J., Zhai, J., Jiang, H., McHugh, J. B., Brenner, J. C., Prince, M. E. P.Language:
english
Journal:
Journal of Neuro-Oncology
DOI:
10.1007/s11060-020-03418-7
Date:
February, 2020
File:
PDF, 2.21 MB
english, 2020